Alnylam Pharmaceuticals
ALNY
#555
Rank
ยฃ33.41 B
Marketcap
ยฃ251.95
Share price
2.01%
Change (1 day)
26.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company